Lavagna-Sévenier C, Marchetto S, Birnbaum D, Rosnet O
Laboratory of Molecular Oncology, INSERM U119, 13009 Marseille, France.
J Biol Chem. 1998 Jun 12;273(24):14962-7. doi: 10.1074/jbc.273.24.14962.
The FLT3 receptor tyrosine kinase and its ligand, FL, play an important role in early hematopoietic development. We have found that CBLB, a recently characterized molecule closely related to the CBL protooncogene product, is phosphorylated on tyrosine(s) following FL treatment of JEA2 human pro-B cells and THP1 monocytic cells. Treatment of JEA2 cells with interleukin (IL)-7 induces CBLB phosphorylation as well. FL and IL-7, respectively, induce and increase association of tyrosine-phosphorylated SHC and the p85 subunit of phosphatidylinositol 3'-kinase with CBLB. In these cells, CBLB constitutively binds the GRB2 adaptor predominantly through its N-terminal SH3 domain, to form a complex that is distinct from the GRB2.CBL and GRB2.SOS1 complexes. Together with the fact that CBLB is consistently found in blast cells from acute leukemias and in peripheral blood mononuclear cells, this suggests that CBLB has a role in tyrosine kinase-regulated signaling pathways in many hematolymphoid cells.
FLT3受体酪氨酸激酶及其配体FL在早期造血发育中起重要作用。我们发现,CBLB是一种最近被鉴定的与CBL原癌基因产物密切相关的分子,在用FL处理JEA2人原B细胞和THP1单核细胞后,CBLB的酪氨酸发生磷酸化。用白细胞介素(IL)-7处理JEA2细胞也会诱导CBLB磷酸化。FL和IL-7分别诱导并增加酪氨酸磷酸化的SHC和磷脂酰肌醇3'-激酶的p85亚基与CBLB的结合。在这些细胞中,CBLB主要通过其N端SH3结构域组成性地结合GRB2衔接蛋白,形成一个不同于GRB2.CBL和GRB2.SOS1复合物的复合物。鉴于在急性白血病的原始细胞和外周血单个核细胞中一直能发现CBLB,这表明CBLB在许多血液淋巴细胞的酪氨酸激酶调节信号通路中起作用。